Literature DB >> 8978236

Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis.

M T Barakat1, J Scott, J M Hughes, M Walport, J Calam, J S Friedland, P W Ind, C McKenna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8978236      PMCID： PMC2353037          DOI： 10.1136/bmj.313.7071.1543

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Malabsorption of antituberculosis medications by a patient with AIDS.

Authors:  S E Berning; G A Huitt; M D Iseman; C A Peloquin
Journal:  N Engl J Med       Date:  1992-12-17       Impact factor: 91.245

2.  Dietary constituents and rifampicin absorption.

Authors:  S D Purohit; S K Sarkar; M L Gupta; D K Jain; P R Gupta; Y R Mehta
Journal:  Tubercle       Date:  1987-06

3.  Effect of meals on rifampicin absorption.

Authors:  D I Siegler; M Bryant; D M Burley; K M Citron; S M Standen
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

Review 4.  Chemotactic cytokines and tuberculosis.

Authors:  J S Friedland
Journal:  Biochem Soc Trans       Date:  1994-05       Impact factor: 5.407

5.  Rifampicin kinetics in undernutrition.

Authors:  K Polasa; K J Murthy; K Krishnaswamy
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

6.  The Australian rifampicin trial.

Authors:  A J Proust
Journal:  Med J Aust       Date:  1971-07-10       Impact factor: 7.738

Review 7.  Pharmacology of the antimycobacterial drugs.

Authors:  C A Peloquin
Journal:  Med Clin North Am       Date:  1993-11       Impact factor: 5.456

Review 8.  Corticosteroids and tuberculosis.

Authors:  T Senderovitz; K Viskum
Journal:  Respir Med       Date:  1994-09       Impact factor: 3.415

9.  Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature.

Authors:  P Muthuswamy; T C Hu; B Carasso; M Antonio; N Dandamudi
Journal:  Chest       Date:  1995-06       Impact factor: 9.410

10.  Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection.

Authors:  J S Friedland; J C Hartley; C G Hartley; R J Shattock; G E Griffin
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330
View more
  1 in total

1.  Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.

Authors:  Prema Gurumurthy; Geetha Ramachandran; A K Hemanth Kumar; S Rajasekaran; C Padmapriyadarsini; Soumya Swaminathan; S Bhagavathy; P Venkatesan; L Sekar; A Mahilmaran; N Ravichandran; P Paramesh
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.